abstract |
The present invention relates to estrogen receptor selective modulators for use in the manufacture of pharmaceutical preparations for use in male androgen deficiency, or for the treatment or prevention of diseases and disorders caused by androgen deficiency, or isomers, isomers thereof. It relates to body mixtures, metabolites, or pharmaceutically acceptable salts thereof. |